BML-275,
Dorsomorphin dihydrochloride,
1219168-18-9,
Dorsomorphin 2HCl,
BML-275,
Compound C,
Dorsomorphin (dihydrochloride),
BML-275 2HCl,
AK175513,
6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine dihydrochloride,
6-[4-[2-(1-PIPERIDINYL)ETHOXY]PHENYL]-3-(4-PYRIDINYL)-PYRAZOLO[1,5-A]PYRIMIDINE DIHYDROCHLORIDE,
6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine;dihydrochloride,
4-(6-{4-[2-(Piperidin-1-yl)ethoxy]phenyl}pyrazolo[1,5-a]pyrimidin-3-yl)pyridine dihydrochloride,
Compound C 2HCl,
BML-275 dihydrochloride,
Compound C dihydrochloride,
Dorsomorphin dihydrochlorid,
SCHEMBL2119244,
CTK8F9363,
Dorsomorphin (Compound C) 2HCl,
KS-00000XOX,
AOB2281,
SYN5171,
BCP06635,
EX-A2050,
BML-275 2HCl,Compound C 2HCl,
FD5027,
MFCD11112197,
s7306,
AKOS024457422,
CS-2482,
MCULE-9260462246,
4CA-0290,
AS-16531,
BC600470,
HY-13418,
QC-11168,
SC-94594,
FT-0700122,
Y1870,
J-004708,
Cl[H].Cl[H].C(CN1CCCCC1)OC1=CC=C(C=C1)C1=CN2N=CC(=C2N=C1)C1=CC=NC=C1,
Pyrazolo[1,5-a]pyrimidine, 6-[4-[2-(1-piperidinyl)ethoxy]phenyl]-3-(4-pyridinyl)-, hydrochloride (1:2),
dorsomorphin (Hydrochloride),
Dorsomorphin-2HClBML-275,
C24H27Cl2N5O,
B1372,
A13720,
866405-64-3,